101 related articles for article (PubMed ID: 8280122)
1. Pioglitazone ameliorates high glucose induced desensitization of insulin receptor kinase in Rat 1 fibroblasts in culture.
Maegawa H; Tachikawa-Ide R; Ugi S; Iwanishi M; Egawa K; Kikkawa R; Shigeta Y; Kashiwagi A
Biochem Biophys Res Commun; 1993 Dec; 197(3):1078-82. PubMed ID: 8280122
[TBL] [Abstract][Full Text] [Related]
2. Thiazolidine derivatives ameliorate high glucose-induced insulin resistance via the normalization of protein-tyrosine phosphatase activities.
Maegawa H; Ide R; Hasegawa M; Ugi S; Egawa K; Iwanishi M; Kikkawa R; Shigeta Y; Kashiwagi A
J Biol Chem; 1995 Mar; 270(13):7724-30. PubMed ID: 7535776
[TBL] [Abstract][Full Text] [Related]
3. Pioglitazone increases insulin sensitivity by activating insulin receptor kinase.
Kobayashi M; Iwanishi M; Egawa K; Shigeta Y
Diabetes; 1992 Apr; 41(4):476-83. PubMed ID: 1318856
[TBL] [Abstract][Full Text] [Related]
4. Troglitazone prevents glucose-induced insulin resistance of insulin receptor in rat-1 fibroblasts.
Kellerer M; Kroder G; Tippmer S; Berti L; Kiehn R; Mosthaf L; Häring H
Diabetes; 1994 Mar; 43(3):447-53. PubMed ID: 7508875
[TBL] [Abstract][Full Text] [Related]
5. Effect of pioglitazone on insulin receptors of skeletal muscles from high-fat-fed rats.
Iwanishi M; Kobayashi M
Metabolism; 1993 Aug; 42(8):1017-21. PubMed ID: 8345805
[TBL] [Abstract][Full Text] [Related]
6. Development of insulin resistance and reversal by thiazolidinediones in C2C12 skeletal muscle cells.
Kumar N; Dey CS
Biochem Pharmacol; 2003 Jan; 65(2):249-57. PubMed ID: 12504800
[TBL] [Abstract][Full Text] [Related]
7. Pioglitazone improves insulin signaling defects in skeletal muscle from Wistar fatty (fa/fa) rats.
Hayakawa T; Shiraki T; Morimoto T; Shii K; Ikeda H
Biochem Biophys Res Commun; 1996 Jun; 223(2):439-44. PubMed ID: 8670300
[TBL] [Abstract][Full Text] [Related]
8. Pioglitazone ameliorates tumor necrosis factor-alpha-induced insulin resistance by a mechanism independent of adipogenic activity of peroxisome proliferator--activated receptor-gamma.
Iwata M; Haruta T; Usui I; Takata Y; Takano A; Uno T; Kawahara J; Ueno E; Sasaoka T; Ishibashi O; Kobayashi M
Diabetes; 2001 May; 50(5):1083-92. PubMed ID: 11334412
[TBL] [Abstract][Full Text] [Related]
9. Potentiation of insulin stimulation of phosphatidylinositol 3-kinase by thiazolidinedione-derived antidiabetic agents in Chinese hamster ovary cells expressing human insulin receptors and L6 myotubes.
Zhang B; Szalkowski D; Diaz E; Hayes N; Smith R; Berger J
J Biol Chem; 1994 Oct; 269(41):25735-41. PubMed ID: 7929278
[TBL] [Abstract][Full Text] [Related]
10. High glucose-induced abnormal epidermal growth factor signaling.
Obata T; Maegawa H; Kashiwagi A; Pillay TS; Kikkawa R
J Biochem; 1998 May; 123(5):813-20. PubMed ID: 9562610
[TBL] [Abstract][Full Text] [Related]
11. Glyburide but not ciglitazone enhances insulin action in the liver independent of insulin receptor kinase activation.
Caro JF; Ittoop O; Sinha MK
Metabolism; 1989 Jul; 38(7):606-11. PubMed ID: 2544783
[TBL] [Abstract][Full Text] [Related]
12. Differential effect of the antidiabetic thiazolidinediones troglitazone and pioglitazone on human platelet aggregation mechanism.
Ishizuka T; Itaya S; Wada H; Ishizawa M; Kimura M; Kajita K; Kanoh Y; Miura A; Muto N; Yasuda K
Diabetes; 1998 Sep; 47(9):1494-500. PubMed ID: 9726240
[TBL] [Abstract][Full Text] [Related]
13. Effect of pioglitazone on vascular reactivity in vivo and in vitro.
Kotchen TA; Zhang HY; Reddy S; Hoffmann RG
Am J Physiol; 1996 Mar; 270(3 Pt 2):R660-6. PubMed ID: 8780234
[TBL] [Abstract][Full Text] [Related]
14. Insulin secretory defect in Zucker fa/fa rats is improved by ameliorating insulin resistance.
de Souza CJ; Yu JH; Robinson DD; Ulrich RG; Meglasson MD
Diabetes; 1995 Aug; 44(8):984-91. PubMed ID: 7622005
[TBL] [Abstract][Full Text] [Related]
15. Pioglitazone-induced increase of insulin sensitivity in the muscles of the obese Zucker fa/fa rat cannot be explained by local adipocyte differentiation.
Hallakou S; Foufelle F; Doaré L; Kergoat M; Ferré P
Diabetologia; 1998 Aug; 41(8):963-8. PubMed ID: 9726600
[TBL] [Abstract][Full Text] [Related]
16. PPAR-gamma overexpression suppresses glucose-induced proinsulin biosynthesis and insulin release synergistically with pioglitazone in MIN6 cells.
Nakamichi Y; Kikuta T; Ito E; Ohara-Imaizumi M; Nishiwaki C; Ishida H; Nagamatsu S
Biochem Biophys Res Commun; 2003 Jul; 306(4):832-6. PubMed ID: 12821117
[TBL] [Abstract][Full Text] [Related]
17. High glucose condition activates protein tyrosine phosphatases and deactivates insulin receptor function in insulin-sensitive rat 1 fibroblasts.
Ide R; Maegawa H; Kikkawa R; Shigeta Y; Kashiwagi A
Biochem Biophys Res Commun; 1994 May; 201(1):71-7. PubMed ID: 8198614
[TBL] [Abstract][Full Text] [Related]
18. Effects of pioglitazone on glucose and lipid metabolism in Wistar fatty rats.
Sugiyama Y; Taketomi S; Shimura Y; Ikeda H; Fujita T
Arzneimittelforschung; 1990 Mar; 40(3):263-7. PubMed ID: 2189419
[TBL] [Abstract][Full Text] [Related]
19. Pioglitazone attenuates the inhibitory effect of phorbol ester on epidermal growth factor receptor autophosphorylation and tyrosine kinase activity.
Takata Y; Imamura T; Yang GH; Takada Y; Sawa T; Morioka H; Kobayashi M
Biochim Biophys Acta; 1996 Jun; 1312(1):68-72. PubMed ID: 8679718
[TBL] [Abstract][Full Text] [Related]
20. Thiazolidinediones ameliorate diabetic nephropathy via cell cycle-dependent mechanisms.
Okada T; Wada J; Hida K; Eguchi J; Hashimoto I; Baba M; Yasuhara A; Shikata K; Makino H
Diabetes; 2006 Jun; 55(6):1666-77. PubMed ID: 16731829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
